Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azacitidine and carboplatin for recurrent pediatric brain and solid tumors
NCT03206021Phase 1Completed
- Sponsor
- SickKids
- Start
- Aug 2017
- Primary completion
- Aug 2022
- Countries
- 3
01
Overview
Phase 1, open-label trial of azacitidine in central nervous system tumor, ependymoma and childhood solid tumor, sponsored by SickKids. Started Aug 2017; status: completed.
02
Drugs
azacitidine
03
Conditions
central nervous system tumorependymomachildhood solid tumor
Beyond the preview
Go deeper on NCT03206021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03206021.